27.01.2015 Views

Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP<br />

21<br />

There is generally no requirement for st<strong>and</strong>ardized SOPs within a health authority or hospital. However,<br />

CTUs affiliated with the BCCA follow that agency’s SOPs. For industry sponsored trials, the sponsor generally<br />

provides a procedures manual specific to the study under investigation.<br />

QA annual audits are generally conducted for the REB <strong>and</strong>/or the clinical facility. For industry sponsored<br />

trials, audits are conducted by the study sponsor <strong>and</strong> may also be conducted by regulatory authorities.<br />

In addition, the UBC Office of Research Services, which manages the ethics review process for hospitals<br />

affiliated with UBC (see below), conducts internal reviews of r<strong>and</strong>omly selected studies that have<br />

received REB approval.<br />

Research Ethics Boards 11<br />

Regulatory Guidelines Followed by Research Ethics Boards in B.C.<br />

The responsibility for ethics in research involving human subjects in B.C. lies primarily with institutional<br />

REBs that follow <strong>and</strong> interpret sets of international <strong>and</strong> national guidelines, codes of ethics or policy<br />

statements to protect human subjects through risk/benefit evaluation, assurance of informed consent,<br />

<strong>and</strong> monitoring of ongoing studies 12 . Investigators intending to conduct human subject research in B.C.<br />

must seek REB approval from the involved institution(s) to satisfy funding <strong>and</strong> regulatory requirements,<br />

institutional policy requirements, <strong>and</strong> to meet criteria for publication in peer-reviewed journals. The<br />

1998 Tri-Council 13 Policy Statement (TCPS): “Ethical Conduct for Research Involving Humans” established<br />

ethical principles as well as requirements <strong>and</strong> prohibitions for REBs in Canada. The TCPS is widely accepted<br />

as the gold st<strong>and</strong>ard to which Canadian REBs aspire for ensuring efficiency <strong>and</strong> fairness to both<br />

human subjects <strong>and</strong> researchers.<br />

In 2006, B.C. REBs reviewed a total of 13,593 research protocols, including 4,465 new applications, 6,473<br />

amendments, <strong>and</strong> 2,655 renewals.<br />

B.C.’s Ethics Review Structure<br />

B.C. has 23 REBs that review research involving human subjects, representing 21 academic institutions,<br />

health authorities, <strong>and</strong> community-based organizations (see Appendix 4). In addition, the for-profit<br />

Canadian Western Institutional Review Board (WIRB) located in Vancouver B.C. <strong>and</strong> based in the U.S.,<br />

provides independent REB services to national multi-centre <strong>and</strong> international clinical trials (see Appendix<br />

11). Through an initiative sponsored by the Michael Smith Foundation for Health Research (MSFHR),<br />

the harmonization of REB processes is in progress. 14<br />

Each of B.C.’s six health authorities is responsible for ensuring ethics review of all research protocols to<br />

be carried out at or by an investigator affiliated with a health care facility within its jurisdiction. Geographically<br />

dispersed REBs provide opportunities to bring local perspectives to the review process, incorporating<br />

knowledge of rural communities, ethnic cultures, <strong>and</strong> other issues of local concern. Four of<br />

the six health authorities have established their own REBs, the other two (VCH <strong>and</strong> PHSA) have reached<br />

agreement with UBC to carry out ethics reviews on their behalf except for the PHSA’s adult oncology<br />

protocols, which are reviewed by the BCCA REB.<br />

11<br />

Extracted from The Ethics Review Process in British Columbia: An Environmental Scan. Michael Smith Foundation for Health Research.<br />

October 2007. www.msfhr.org/resources/public/Reports/BC_Scan.pdf. Accessed October 21, 2009.<br />

12<br />

Include: the Nuremberg Code (1948), the Helsinki Declaration (1964), the Belmont Report from The National Commission for the<br />

Protection of Human Subjects of Biomedical <strong>and</strong> Behavioral Research (1979), <strong>and</strong> the International Conference on Harmonization<br />

(ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use guidelines established in 1990 by the European<br />

Union, Japan <strong>and</strong> the U.S.<br />

13<br />

Tri-Council refers to Canada’s three federal research funding agencies: the Canadian Institutes of Health Research (CIHR), the Social<br />

<strong>Sciences</strong> <strong>and</strong> Humanities Research Council (SSHRC), <strong>and</strong> the Natural <strong>Sciences</strong> <strong>and</strong> Engineering Research Council (NSERC).<br />

14<br />

http://www.msfhr.org/special_initiatives/ethics_harmonization. Accessed October 21, 2009.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!